HOT NEWS
Boehringer Ingelheim
Boehringer IngelheimThe Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 135 affiliates in 47 countries and almost 38,900 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine. In 2007, Boehringer Ingelheim posted net sales of 10.9 billion euro while spending one fifth of net sales in its largest business segment Prescription Medicines on research and development. For more information please visit www.boehringer-ingelheim.com.

Boehringer Ingelheim RSS Channel

Title Filter     Display # 
# Article Title Hits
1 Boehringer Ingelheim launches 'Lean-to-Clinic' program for fast drug product supply 680
2 Boehringer Ingelheim gains approval of extended 4.5 hour time-window for Actilyse® 2406
3 Boehringer Ingelheim and AVEO Pharmaceuticals announce manufacturing agreement for ficlatuzumab 2776
4 Boehringer Ingelheim implements additional guidance supporting appropriate use of Pradaxa® (dabigatran etexilate) in Europe 2925
5 Boehringer Ingelheim and Gilead sign license agreement for novel HIV non-catalytic integrase inhibitors 2939
6 European Respiratory Society (ERS) Awards Annual COPD Research Prize 3522
7 Boehringer Ingelheim and EFSD collaborate to support diabetes research in Europe 3931
8 Boehringer Ingelheim wins Frost & Sullivan Award for Biopharmaceutical Contract Manufacturing 3360
9 €1 Million Awarded to Winning Projects 3289
10 Trajenta® (linagliptin) receives approval for the treatment of type 2 diabetes in Europe 4067
11 Boehringer Ingelheim licenses ProBioGen's novel GlymaxX® technology 3921
12 Positive first half-year 2011 for Boehringer Ingelheim 3017
13 PRADAXA® first drug in 50 years to gain approval for stroke prevention in atrial fibrillation 3605
14 Stroke prevention: "It is time to act" 3110
15 Boehringer Ingelheim maintains sales level/course set for the future: product pipeline well-filled 4337
16 MorphoSys Signs Manufacturing Agreement with Boehringer Ingelheim 4575
17 Pfēnex Inc. and Boehringer Ingelheim Announce Non-Exclusive Strategic Agreement 4922
18 Boehringer Ingelheim and Eli Lilly and Company Announce Strategic Alliance 5487
19 LUX-Lung 1 trial suggests benefit from afatinib* in lung cancer patients 5692
20 Boehringer Ingelheim steps up to the challenge in support of World Diabetes Day 5532
 
  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  Next 
  •  End 
  • »
Page 1 of 3
Bookmark and Share